The Immunogenicity and Safety of the Live-attenuated SA 14-14-2 Japanese Encephalitis Vaccine Given with a Two-dose Primary Schedule in Children

Effective and tolerable vaccination is an essential strategy to prevent Japanese encephalitis (JE) in endemic areas. Although the live attenuated SA 14-14-2 JE vaccine (LAJEV) has been widely used since its introduction, the systemic data of LAJEV was very rarely available in Korea. We conducted the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Hyo Jin, Lee, Soo Young, Kim, Ki Hwan, Kim, Dong Soo, Cha, Sung Ho, Jo, Dae Sun, Kang, Jin Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414646/
https://www.ncbi.nlm.nih.gov/pubmed/25931793
http://dx.doi.org/10.3346/jkms.2015.30.5.612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4414646/
https://www.ncbi.nlm.nih.gov/pubmed/25931793
http://dx.doi.org/10.3346/jkms.2015.30.5.612

Ejemplares similares